Immunovant, Inc.

NasdaqGS:IMVT 株式レポート

時価総額:US$3.9b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Immunovant 所有権

大株主は誰で、インサイダーは売買しているのか?


最近のインサイダー取引

NasdaqGS:IMVT 企業または個人による最近のインサイダー取引
日付価値名称エンティティ役割株式最高価格
22 May 24SellUS$96,125Mark LevineIndividual3,242US$29.65
22 May 24SellUS$96,274William MaciasIndividual3,247US$29.65
22 May 24SellUS$96,274Julia ButchkoIndividual3,247US$29.65
22 May 24SellUS$479,233Peter SalzmannIndividual16,163US$29.65
22 May 24SellUS$119,845Eva BarnettIndividual4,042US$29.65
24 Apr 24SellUS$114,531Mark LevineIndividual3,963US$28.90
24 Apr 24SellUS$94,243Michael GeffnerIndividual3,261US$28.90
24 Apr 24SellUS$209,207Jay StoutIndividual7,239US$28.90
17 Apr 24SellUS$990,269Peter SalzmannIndividual34,079US$29.94
17 Apr 24SellUS$293,923Julia ButchkoIndividual10,115US$29.94
17 Apr 24SellUS$285,554Mark LevineIndividual9,827US$29.94
17 Apr 24SellUS$356,049Eva BarnettIndividual12,253US$29.94
17 Apr 24SellUS$240,602William MaciasIndividual8,280US$29.94
09 Apr 24SellUS$149,882Peter SalzmannIndividual4,807US$31.18
09 Apr 24SellUS$115,023Eva BarnettIndividual3,689US$31.18
09 Apr 24SellUS$32,833Julia ButchkoIndividual1,053US$31.18
22 Feb 24SellUS$486,362Peter SalzmannIndividual13,454US$36.15
22 Feb 24SellUS$77,144Mark LevineIndividual2,134US$36.15
22 Feb 24SellUS$77,578Julia ButchkoIndividual2,146US$36.15
22 Feb 24SellUS$80,289William MaciasIndividual2,221US$36.15
22 Feb 24SellUS$105,920Eva BarnettIndividual2,930US$36.15
26 Jan 24SellUS$114,778Mark LevineIndividual3,027US$38.45
26 Jan 24SellUS$383,012Michael GeffnerIndividual10,101US$38.45
18 Jan 24SellUS$17,397William MaciasIndividual424US$41.03
11 Jan 24SellUS$147,023Eva BarnettIndividual3,515US$42.43
05 Jan 24SellUS$147,568Peter SalzmannIndividual3,824US$38.59
05 Jan 24SellUS$50,051Julia ButchkoIndividual1,297US$38.59
01 Dec 23SellUS$490,668Atul PandeIndividual12,350US$40.46
22 Nov 23SellUS$106,598Mark LevineIndividual3,252US$33.52
22 Nov 23SellUS$107,024Julia ButchkoIndividual3,265US$33.52
22 Nov 23SellUS$531,581Peter SalzmannIndividual16,217US$33.52
22 Nov 23SellUS$107,024William MaciasIndividual3,265US$33.52
22 Nov 23SellUS$132,920Eva BarnettIndividual4,055US$33.52
25 Oct 23SellUS$142,349Mark LevineIndividual4,107US$34.66
19 Oct 23SellUS$19,504William MaciasIndividual530US$36.80
10 Oct 23SellUS$168,244Eva BarnettIndividual4,557US$36.92
05 Oct 23SellUS$189,887Peter SalzmannIndividual5,239US$36.39
05 Oct 23SellUS$62,885Julia ButchkoIndividual1,735US$36.39
02 Oct 23BuyUS$58,000,008Roivant Sciences Ltd.Company1,526,316US$38.00
30 Aug 23SellUS$1,250,338Peter SalzmannIndividual56,774US$22.48
24 Aug 23SellUS$250,340Julia ButchkoIndividual12,332US$20.30
24 Aug 23SellUS$292,016Eva BarnettIndividual14,385US$20.30
24 Aug 23SellUS$249,386Mark LevineIndividual12,285US$20.30
24 Aug 23SellUS$250,340William MaciasIndividual12,332US$20.30
24 Aug 23SellUS$21Julia ButchkoIndividual1US$20.89
24 Aug 23SellUS$21Eva BarnettIndividual1US$20.89
24 Aug 23SellUS$21Mark LevineIndividual1US$20.89
24 Aug 23SellUS$21William MaciasIndividual1US$20.89
14 Aug 23SellUS$2,207,178Peter SalzmannIndividual103,058US$22.04
07 Aug 23SellUS$2,202,096Peter SalzmannIndividual101,339US$21.73
26 Jul 23SellUS$84,725Mark LevineIndividual3,917US$21.63
19 Jul 23SellUS$67,962Eva BarnettIndividual2,725US$24.94
19 Jul 23SellUS$10,624William MaciasIndividual426US$24.94
12 Jul 23SellUS$29,003Julia ButchkoIndividual1,470US$19.73
12 Jul 23SellUS$63,787Peter SalzmannIndividual3,233US$19.73

インサイダー取引量

インサイダー購入: IMVT インサイダー は過去 3 か月間に株式を売却しただけです。


所有権の内訳

IMVT の所有者構成は?
オーナータイプ株式数所有比率
民間企業5120.000339%
個人インサイダー1,218,6280.807%
機関70,054,50746.4%
上場企業79,805,33152.8%

株式の希薄化: 過去1年間で株主は希薄化し、発行済み株式総数は12%増加しました。


上位株主

25 上位株主88.45 %を所有。
所有権名称株式現在の価値変化率ポートフォリオ
54.6%
Roivant Sciences Ltd.
79,805,331US$2.1b0%データなし
5.24%
FMR LLC
7,655,938US$202.3m-2.79%0.01%
4.44%
The Vanguard Group, Inc.
6,478,304US$171.2m11.2%データなし
3.07%
BlackRock, Inc.
4,476,800US$118.3m-1.19%データなし
2.49%
State Street Global Advisors, Inc.
3,641,907US$96.2m13.2%データなし
2.03%
Perceptive Advisors LLC
2,963,212US$78.3m27.3%1.69%
1.48%
Armistice Capital LLC
2,164,000US$57.2m50.7%1.64%
1.29%
Alpine Global Management, LLC
1,882,704US$49.7m34.6%14.04%
1.27%
T. Rowe Price Group, Inc.
1,862,043US$49.2m16.2%データなし
1.24%
Viking Global Investors LP
1,809,172US$47.8m0%0.19%
1.22%
Logos Global Management, L.P.
1,775,000US$46.9m47.9%5.95%
0.95%
Point72 Asset Management, L.P.
1,383,810US$36.6m-48.3%0.08%
0.9%
Geode Capital Management, LLC
1,316,827US$34.8m3.45%データなし
0.88%
Woodline Partners LP
1,289,504US$34.1m71.9%0.33%
0.87%
Fred Alger Management, LLC
1,271,762US$33.6m43.7%0.15%
0.87%
Pictet Asset Management Limited
1,265,298US$33.4m-3.22%0.02%
0.79%
Rock Springs Capital Management LP
1,150,123US$30.4m17%0.83%
0.69%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,003,897US$26.5m-10.9%0.01%
0.67%
Capital Research and Management Company
976,237US$25.8m0%データなし
0.66%
Redmile Group, LLC
969,621US$25.6m-0.76%1.14%
0.59%
Morgan Stanley, Investment Banking and Brokerage Investments
856,061US$22.6m90.2%データなし
0.56%
Tavistock Life Sciences
825,000US$21.8m-17.5%1.17%
0.55%
Franklin Resources, Inc.
809,478US$21.4m50.2%0.01%
0.55%
Paradigm Biocapital Advisors LP
799,054US$21.1m0%0.85%
0.51%
Commodore Capital LP
750,990US$19.8m-24.9%1.51%